Bayer Escapes Bulk Of Trasylol Off-Label Marketing Suit
By Andrew Scurria · April 14, 2014, 7:37 PM EDT
A New Jersey federal judge on Friday cut down a long-running employee whistleblower suit accusing Bayer Corp. of fleecing government health programs by pushing off-label uses of heart-surgery drug Trasylol and...
To view the full article, register now.